Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 255.93B P/E 16.25 EPS this Y - Ern Qtrly Grth 9.30%
Income 14.66B Forward P/E - EPS next Y - 50D Avg Chg -3.00%
Sales 67.95B PEG - EPS past 5Y 4.84% 200D Avg Chg -6.00%
Dividend 24.00% Price/Book 9.92 EPS next 5Y 7.10% 52W High Chg -28.00%
Recommedations 1.30 Quick Ratio 0.65 Shares Outstanding 6.40B 52W Low Chg 3.00%
Insider Own - ROA 15.59% Shares Float 5.46B Beta 0.21
Inst Own 1.29% ROE 45.13% Shares Shorted/Prior -/- Price 39.00
Gross Margin 70.77% Profit Margin 21.57% Avg. Volume 1,307,054 Target Price 47.80
Oper. Margin 32.05% Earnings Date - Volume 1,324,240 Change -0.74%
About ROCHE HOLDINGS AG SPN ADR EACH

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. It has a research collaboration agreement with Synlogic, Inc. for the discovery of a novel synthetic biotic for the treatment of inflammatory bowel disease (IBD). The company was founded in 1896 and is headquartered in Basel, Switzerland.

ROCHE HOLDINGS AG SPN ADR EACH News
01/26/23 Roche Introduces Test To Detect Contagious XBB.1.5 Omicron Sub-Variant
01/26/23 Roche launches new test to detect fast spreading Omicron sub-variant
01/26/23 Roche launches COVID-19 PCR test to detect the fast spreading XBB.1.5 Omicron sub-variant
01/19/23 Roche (RHHBY) Tecentriq Meets Adjuvant Liver Cancer Study Goal
01/19/23 Genentech's Tecentriq Plus Avastin Combo Cuts Risk of Cancer Returning In Early-Stage Liver Cancer
01/19/23 Genentech’s Tecentriq Plus Avastin Is the First Treatment Combination to Reduce the Risk of Cancer Returning in People With Certain Types of Early-Stage Liver Cancer in a Phase III Trial
01/19/23 [Ad hoc announcement pursuant to Art. 53 LR] Roche’s Tecentriq plus Avastin is the first treatment combination to reduce the risk of cancer returning in people with certain types of early-stage liver cancer in a Phase III trial
01/17/23 The Zacks Analyst Blog Highlights UnitedHealth Group, The Coca-Cola, Roche Holding, Lam Research and Valero Energy
01/16/23 Biogen (BIIB) Partner Eisai Seeks Nod for Lecanemab in Japan
01/16/23 Top Research Reports for UnitedHealth Group, Coca-Cola & Roche Holding
01/12/23 Roche (RHHBY) Gets EU Approval for Xofluza in New Patient Base
01/12/23 Halozyme (HALO) Down 9.2% on Weak 2023 Financial Guidance
01/12/23 Europe Approves Xofluza, Roche's Revolutionary Influenza Antiviral with New Mechanism
01/12/23 Roche announces the European Commission approval of Xofluza for the treatment and prevention of influenza in children aged one year and above
01/10/23 Regeneron (REGN) Down on Ophthalmology Drug Eylea Sales Update
01/09/23 Kronos Bio’s stock rallies after announcing drug-discovery deal with Roche
01/09/23 15 Biggest Non-Tech Companies in the World by Market Cap
01/06/23 Roche's (RHHBY) Cancer Drug Glofitamab Gets FDA Priority Review
01/06/23 Roche's Investigational Lymphoma Candidate Goes Under FDA Priority Review
01/06/23 FDA Grants Priority Review to Genentech’s Bispecific Antibody Glofitamab for People With Relapsed or Refractory Large B-Cell Lymphoma
RHHBY Chatroom

User Image saxy4u Posted - 18 hours ago

$PFE $MRK $RHHBY $BMY who is going to buy $ONCY ??? Major data is coming, in 90 exclusivity with Pfizer, should be released soon! Canadian biotech way under radar!

User Image cctranscripts Posted - 3 days ago

Major owner of Roche Holding Ltd just disposed of 75,000 shares https://www.conferencecalltranscripts.org/summary/?id=11730452 $RHHBY

User Image STCKPRO Posted - 4 days ago

$RHHBY NEW ARTICLE : Roche launches COVID-19 PCR test to detect the fast spreading XBB.1.5 Omicron sub-variant https://www.stck.pro/news/RHHBY/41413811

User Image cctranscripts Posted - 4 days ago

Roche launches COVID-19 PCR test to detect the fast spreading XBB.1.5 Omicron sub-variant https://conferencecalltranscripts.com/summary/?id=489328&pr=true $RHHBY

User Image Stock_Titan Posted - 4 days ago

$RHHBY Roche launches COVID-19 PCR test to detect the fast spreading XBB.1.5 Omicron sub-variant https://www.stocktitan.net/news/RHHBY/roche-launches-covid-19-pcr-test-to-detect-the-fast-spreading-xbb-1-bm1kjnfao9qu.html #covid19

User Image Alberto1976 Posted - 5 days ago

"Among healthcare stocks, Eagle Pharmaceuticals is an interesting opportunity to benefit from volatility in stock markets. [...]" primary ticker: $egrx secondary tickers: $biib $rhhbf $RHHBY continue reading the article here: https://seekingalpha.com/article/4572186-eagle-pharmaceuticals-upside-could-be-lying-ahead-very-nicely?v=1674653582#comment-94313650

User Image snosrap Posted - 5 days ago

$LCTX $PTCT had a $RHHBY deal too with milestones. Not a straight line just looking for some crumbs https://ir.ptcbio.com/news-releases/news-release-details/ptc-therapeutics-announces-first-commercial-milestone-payment

User Image 6Wallstreet9 Posted - 6 days ago

$IBIO Seems like PR today. Wondering if our Ibio-101 data is still better than expected against $RHHBY data acquisition. Or maybe the CDMO Facility has been divested to push our incredible oncology pipeline forward with patented AI technology everyone's interested in. Dr. Martin Brenner has successfully demonstrated antibody work at $PFNX and surprise suprise...both $IBIO and them are in San Diego. Good luck everyone

User Image BusinessInAudio Posted - 1 week ago

How To Calculate Intrinsic Value (Full Example) https://www.audea.io/audea?id=WL3n7TWtqrM $PFE $JNJ $NVS $ABT $LLY $CVS $UNH $TDOC $CRSP $RHHBY

User Image ne8 Posted - 1 week ago

$ALLR Foundation Medicine (FMI) is a genomic testing company that was acquired by Roche ($RHHBY, $43.43, Not Rated) in 2018 in a $2.4B deal. Genomic Health is a genomic test diagnostic company acquired by Exact Sciences ($EXAS, $49.86, Not Rated) in 2019 in a $2.8B deal. Those companies did Ladenburg Thalmann compare with Allarity. These were acquired in 2018-2019 for their genomics technology to identify various diseases: ”The HCC registrational trial for dovitinib may be performed as the Simon two-stage design trial with a prespecified ORR and some 67% DRP score. However, the HCC trial is likely the strategy of $ALLR once RCC trial is up and running or if/when $ALLR is acquired by a larger biopharma player.” https://s28.q4cdn.com/241540924/files/ALLR-initiation-report-5.27.22.pdf

User Image nlrmandate Posted - 1 week ago

$TGTX hey $MRK $SNY may want to consider buying $TGTX….Ubli has some significant advantages over Ocrevus and TG may well be able to take substantial market share from $RHHBY’s Ocrevus

User Image STCKPRO Posted - 1 week ago

$RHHBY NEW ARTICLE : [Ad hoc announcement pursuant to Art. 53 LR] Roche's Tecentriq plus Avastin is the first treatment combination to reduce the risk of cancer returning in people with certain types of early-stage liver cancer in a Phase III trial https://www.stck.pro/news/RHHBY/41044564

User Image otcdynamics Posted - 1 week ago

$RHHBY Genentech’s Tecentriq Plus Avastin Is the First Treatment Combination to Reduce the Risk of Cancer Returning in People With Certain Types of Early-Stage Liver Cancer in a Phase III Trial https://www.otcdynamics.com/rhhby-genentechs-tecentriq-plus-avastin-is-the-first-treatment-combination-to-reduce-the-risk-of-cancer-returning-in-people-with-certain-types-of-early-stage-liver-cancer-in-a-phase-iii-tria

User Image STCKPRO Posted - 1 week ago

$RHHBY NEW ARTICLE : Genentech's Tecentriq Plus Avastin Is the First Treatment Combination to Reduce the Risk of Cancer Returning in People With Certain Types of Early-Stage Liver Cancer in a Phase III Trial https://www.stck.pro/news/RHHBY/41044723

User Image cctranscripts Posted - 1 week ago

[Ad hoc announcement pursuant to Art. 53 LR] Roche’s Tecentriq plus Avastin is the first treatment combination to reduce the risk of cancer returning in people with certain types of early-stage liver cancer in a Phase III trial https://conferencecalltranscripts.com/summary/?id=485135&pr=true $RHHBY

User Image Stock_Titan Posted - 1 week ago

$RHHBY [Ad hoc announcement pursuant to Art. 53 LR] Roche’s Tecentriq plus Avastin is the first treatment combination to reduce the risk of cancer returning in people with certain types of early-stage liver cancer in a Phase III trial https://www.stocktitan.net/news/RHHBY/ad-hoc-announcement-pursuant-to-art-53-lr-roche-s-tecentriq-plus-epn71znamt5j.html #cancer

User Image STCKPRO Posted - 1 week ago

$RHHBY NEW ARTICLE : Relay Therapeutics: Tall Claims, Some Proofs Of Concept, Some Concerns https://www.stck.pro/news/RHHBY/41034387

User Image MarketBeat Posted - 1 week ago

Roche downgraded by Deutsche Bank Aktiengesellschaft to sell. www.marketbeat.com/stocks/OTCMKTS/RHHBY/price-target/ $RHHBY

User Image greatwhiteshark Posted - 1 week ago

$LCTX $RHHBY added Cincinnati Eye Institute as recruiting location for the upcoming OpRegen trial in the January 16th update: https://clinicaltrials.gov/ct2/history/NCT05626114?A=2&B=3&C=Side-by-Side#StudyPageTop

User Image ObeCalp Posted - 1 week ago

$RHHBY Wish Roche had options to buy. Volume has been interesting of late.

User Image stocksaudio1 Posted - 1 week ago

How To Calculate Intrinsic Value (Full Example) https://www.audea.io/audea?id=WL3n7TWtqrM $PFE $JNJ $NVS $ABT $LLY $CVS $UNH $TDOC $CRSP $RHHBY

User Image BuBleRunner Posted - 2 weeks ago

$TEVA $PFE $nov $BNTX $RHHBY

User Image Young_Antarian Posted - 2 weeks ago

$INFI partner BO could be $BMY or $RHHBY

User Image STCKPRO Posted - 2 weeks ago

$RHHBY NEW ARTICLE : Roche announces the European Commission approval of Xofluza for the treatment and prevention of influenza in children aged one year and above https://www.stck.pro/news/RHHBY/40667946

User Image cctranscripts Posted - 2 weeks ago

Roche announces the European Commission approval of Xofluza for the treatment and prevention of influenza in children aged one year and above https://conferencecalltranscripts.com/summary/?id=481782&pr=true $RHHBY

User Image Stock_Titan Posted - 2 weeks ago

$RHHBY Roche announces the European Commission approval of Xofluza for the treatment and prevention of influenza in children aged one year and above https://www.stocktitan.net/news/RHHBY/roche-announces-the-european-commission-approval-of-xofluza-for-the-hp4chp21hdko.html

User Image clinician55 Posted - 2 weeks ago

$PACB Another similar type example, some might recall was Roche's $RHHBY acquisition of Foundation Medicine $FMI. Foundation Medicine's biggest asset was the data they'd collected on tumor mutations - through vast genetic sequencing. Roche bought them for that dataset, well an the business of sequencing tumors. A company like $GOOG is all about data mining and collection, so the strategic agreement between $PACB and $GOOG makes sense, but I'd wager Google takes that a step further at some point. Well I guess I sort have wagered that by purchasing $PACB stock. LOL.

User Image STOCK6996 Posted - 2 weeks ago

$BJDX $RHHBY 🙏

User Image stocksaudiocontent Posted - 2 weeks ago

Buffett: How To Turn Small Sums Of Money Into Large Ones https://www.audea.io/audea?id=YD_5kDMY1Nr $PFE $JNJ $NVS $ABT $LLY $CVS $UNH $TDOC $CRSP $RHHBY

User Image GOODluck19 Posted - 2 weeks ago

$SONN ah so they have a treatment that theyre working on with $RHHBY and $JNJ and one cant hold for a few months ? oiiiiii dum dums

Analyst Ratings
Cowen & Co. Market Perform Nov 15, 22
Cowen & Co. Outperform Jun 27, 22
Cowen & Co. Outperform Jan 10, 22
Deutsche Bank Buy Jul 8, 21
Argus Buy Jan 28, 19
Credit Suisse Neutral Jan 28, 19
Goldman Sachs Buy Nov 19, 18
Credit Suisse Underperform May 25, 18
Bernstein Market Perform May 10, 18